Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
Stocks Up After Powell Comments
Ed Siddell, CEO and chief investment officer of EGSI Financial, joined Cheddar News to discuss Tuesday's market session as stocks traded higher after Fed Chair Jerome Powell gave a favorable glimpse into disinflation.
Load More